James Van Rensselaer Hunt Freeman MD MPH, MS

PubMed

• Incidence, Prevalence, and Trends in Mortality and Stroke among Medicare Beneficiaries With Atrial Fibrillation: 2013 to 2019.
  Nichole M Rogovoy, Stephen Kearing, Weiping Zhou, James V Freeman, Jonathan P Piccini
  Circulation. Cardiovascular Quality and Outcomes. 2025-04-04
• 1 citations
  Amulet LAAO 5-Year Outcomes: Best in Class or Class Effect?
  Daniel J Friedman, James V Freeman
  Journal of the American College of Cardiology. 2025-03-25
• Association of Physician Certification and Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion.
  Amit N Vora, Lucy A Pereira, Chengan Du, Zhen Tan, Chien Yu Huang
  JACC. Cardiovascular Interventions. 2025-03-10

Journal Articles

• Digoxin and Risk of Death in Adults with Atrial Fibrillation: The ATRIA-CVRN Study  
  Freeman JV, Reynolds K, Fang M, Udaltsova N, Steimle A, Pomernacki, NK, Borowsky, LH, Harrison TN, Singer DE, Go AS, Circ Arrhythm Electrophysiol, 1/20/2014
• Effectiveness and Safety of Digoxin Among Contemporary Adults With Incident Systolic Heart Failure  
  Freeman JV, Yang J, Sung SH, Hlatky MA, Go AS, Circ Cardiovasc Qual Outcomes, 1/1/2013
• Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation  
  Hess PL, Kim S, Piccini JP, Allen LA, Ansell JE, Chang P, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Thomas L, Peterson ED, Fonarow GC, Am J Med, 1/1/2013
•  
  Chang TI, Yang J, Freeman JV, Hlatky MA, Go AS, J Card Fail, 1/1/2013
• Procedural Complications, Re-hospitalization, and Repeat Procedures After Catheter Ablation for Atrial Fibrillation  
  Shah RU, Freeman JV, Shilane D, Wang PJ, Go AS, Hlatky MA, J Am Coll Cardiol, 1/10/2012
• Cost-effectiveness of pharmacologic and invasive therapies for stroke prophylaxis in atrial fibrillation  
  Solomon MD, Ullal AJ, Hoang DD, Freeman JV, Heidenreich P, Turakhia MP, J Cardiovasc Med, 1/1/2012
• Is Less More?: Dual- Versus Single-Chamber Implantable Cardioverter-Defibrillators  
  Al-Ahmad A, Freeman JV, J Am Coll Cardiol, 1/30/2011
• Dabigatran compared with warfarin for stroke prevention in atrial fibrillation  
  Freeman JV, Turakhia MP, Ann. Intern Med, 1/19/2011
• Procedure Volume and Outcome: You should take into account each hospital  
  Freeman JV,Wang Y, Curtis J, Heidenreich PA, Hlatky MA, J Am Coll Cardiol, 1/19/2011
• Physician Procedure Volume and Complications of Cardioverter-Defibrillator Implantation  
  Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA, Circulation, 1/17/2011
• Interpretation of the electrocardiogram of young athletes  
  Uberoi A, Stein R, Perez MV, Freeman J, Wheeler M, Dewey F, Peidro R, Hadley D, Drezner J, Sharma S, Pelliccia A, Corrado D, Niebauer J, Estes NAM, Ashley E, Froelicher V, Circulation, 1/9/2011
• Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in nonvalvular atrial fibrillation  
  Freeman JV, Zhu RP, Hutton D, Owens DK, Garber A,Go AS, Wang PJ, Turakhia M, Ann Intern Med, 1/1/2011
• The Impact of ST Elevation on Athletic Screening  
  Leo T, Uberoi A, Jain NA, Garza D, Chowdhury S, Freeman JV, Perez M, Ashley E, Froelicher V, Clin J Sport Med, 1/1/2011
• Cost Effectiveness of Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy  
  Freeman JV, Ullal A, Turakhia MP, Cardiac Electrophysiology Clinics, 1/1/2011
• The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the National Cardiovascular Data Registry  
  Freeman JV,Wang Y, Curtis J, Heidenreich PA, Hlatky MA, J Am Coll Cardiol, 1/1/2010
• Statin Use and Ventricular Arrhythmias During Clinical Treadmill Testing  
  Dewey FE, Perez M, Hadley DM, Freeman JV, Myers JN, Wang P, Ashley E, Myers J, Froelicher VF, J Cardiovasc Electrophysiol, 1/1/2009
• Should the exercise ECG be used to screen for sudden cardiac death?  
  Freeman J, Ashley EA, Froelicher V, Eur Heart J, 1/1/2009
• The Ageing Athlete: Screening Prior to Vigorous Exertion in Asymptomatic Adults without Known Cardiovascular Disease  
  Freeman J, Froelicher V, Ashley E, British Journal of Sports Medicine, 1/1/2009
• Adding an electrocardiogram to the pre-participation examination in competitive athletes: a systematic review  
  Perez M, Fonda H, Le VV, Mitiku T, Ray J, Freeman JV, Ashley E, Froelicher VF, Curr Probl Cardiol, 1/1/2009
• Prediction of Cardiovascular Death Using a Novel Heart Rate Recovery Parameter  
  Hadley DM, Dewey FE, Freeman JV, Myers JN, Froelicher VF, Med Sci Sports Exerc, 1/1/2008
• Novel Predictor of Prognosis from Exercise Stress Testing: Heart Rate Variability Response to the Exercise Treadmill Test  
  Dewey FE, Freeman JV, Engel G, Oviedo R, Abrol N, Ahmed N, Myers J, Froelicher VF, Am Heart J, 1/1/2007
• Autonomic Nervous System Interaction with the Cardiovascular System During Exercise  
  Freeman JV, Dewey FE, Hadley DM, Meyers J, Froelicher VF, Prog Cardiovasc Dis, 1/1/2006
• Evaluation of neonatal verbal autopsy using physician review versus algorithm-based cause-of-death assignment in rural Nepal  
  Freeman JV, Christian P, Khatry SK, Adhikari RK, LeClerq SK, Katz J, Darmstadt, GL, Paediatr Perinat Epidemiol, 1/1/2005
• Join now to see all

Books/Book Chapters

• Core Concepts in Health 
  Chapter: Cardiovascular Health 
  Freeman JV2009
• Concise Cardiology 
  Chapter: Bradyarrhythmias 
  Freeman JV and Wang P2008

Abstracts/Posters

• Long-Term Device-Related Adverse Events After Implantable Cardioverter-Defibrillator Therapy
  Isuru Ranasinghe, Craig Parzynski, James V Freeman, Rachel P Dreyer, Joseph S Ross, Joseph G Akar, Harlan M Krumholz, Jeptha P. Curtis, American Heart Association Scientific Sessions, 1/1/2014
• Impact of the 2014 Atrial Fibrillation Guideline on the Proportion of Patients Recommended for Oral Anticoagulation
  Emily C O'Brien, Sunghee Kim, Paul L. Hess, James V. Freeman, Laine Thomas, Gregg C. Fonarow, Jack E. Ansell, Peter R. Kowey, Elaine M. Hylek, Kenneth W. Mahaffey, Pau..., American Heart Association Scientific Sessions, 1/1/2014
• Sinus Node Dysfunction in Associated With Higher Symptom Burden and Increased Risk of Progression to Permanent Atrial Fibrillation: Results From ORBIT-AF Registry
  Larry R Jackson II, Sung Hee Kim, Jonathan P Piccini Sr, Bernard J Gersh, Gerald V Naccarelli, James A Reiffel, James Freeman, Laine Thomas, Paul Chang, Gregg C Fonaro..., American Heart Association Scientific Sessions, 1/1/2014
• The Early Repolarization Pattern in Athletes: A Systematic Review and Meta-Analysis
  Aditya J. Ullal, Donald Huang, Marco Perez, James V. Freeman, Claire Than, Paul Heidenreich, Mintu Turakhia, Heart Rhythm Society Annual Scientific Sessions, 1/1/2014
• Multimodality Imaging Approach to Minimize Fluoroscopy During Atrial Fibrillation Ablation
  Rashad Khazi Syed, John Novella, Neil Brysiewicz, James V. Freeman, Jude Clancy, Mark Marieb, Joseph Akar, Heart Rhythm Society Annual Scientific Sessions, 1/1/2014
• How Consistent are the ECG Diagnostic Criteria for Early Repolarization Pattern Across Studies?
  Aditya J. Ullal, Donald Huang, Marco Perez, James V. Freeman, Claire Than, Paul Heidenreich, Mintu Turakhia, Heart Rhythm Society Annual Scientific Sessions, 1/1/2014
• Cost-Effectiveness of Single-Chamber Compared with Dual-Chamber and Single-Lead with Atrial Sensing Implantable Cardioverter Defibrillators
  James V. Freeman, Michael J. Harvey, Jay P. Thaker, David Hutton, American Heart Association Scientific Sessions, 1/1/2014
• Molecular Autopsy for Sudden Cardiac Death Using Whole Genome Sequencing
  Frederick E. Dewey, Matthew T. Wheeler, Sergio Cordero, Marco V. Perez, Aleks Pavlovic, Dmitry Pushkarev, James V. Freeman, Steve R. Quake, Euan A. Ashley, American College of Cardiology Scientific Sessions, 1/1/2011
• Cost-effectiveness of Percutaneous Left Atrial Appendage Occlusion versus warfarin for atrial fibrllation
  Mintu P. Turakhia, Ruo P. Zhu, Susan Bobulsky, Douglas K. Owens, Alan Garber, Amin Al-Ahmad, Paul J. Wang, James V. Freeman, CARDIOSTIM Scientific Sessions, 1/1/2010
• Cost-effectiveness of Percutaneous Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation
  Mintu P. Turakhia, Ruo P. Zhu, Susan Bobulsky, Douglas K. Owens, Alan Garber, James V.Freeman, Heart Rhythm Society Scientific Sessions, 1/1/2010
• Non-Linear Analysis of Heart Rate Variability During Recovery from Treadmill Testing Predicts Cardiovascular Prognosis
  Frederick E. Dewey, James V. Freeman, David Hadley, Jonathan Myers, Victor F. Froelicher, American College of Cardiology Annual Scientific Session, 1/1/2007
• Novel Predictor of Prognosis from Exercise Testing: Heart Rate Variability Response to the Exercise Treadmill Test
  Frederick E. Dewey, James Freeman, Greg Engel, Raul Pinoviedo, Nayana Abrol, Natasha Ahmed, Jonathan Myers, Victor F. Froelicher, American College of Cardiology Annual Scientific Session, 1/1/2006
• Can Exercise Induced Heart Rate Variability Spectral Slopes Provide Insights Into Autonomic Activity and Prognosis?
  David M. Hadley, James V. Freeman, Frederick E. Dewey, Gregory Engel, Victor F. Froelicher, American College of Cardiology Annual Scientific Session, 1/1/2006
• Heart Rate Variability Response to Dynamic Exercise Testing: Implications for Interpretation of Spectral Analysis Parameters During Periods of Less Oscillatory Autonom...
  Frederick E. Dewey, James V. Freeman, Gregory Engel, Raul Pinoviedo, Natasha Ahmed, Johnathan Myers, Victor F. Froelicher, American College of Cardiology Annual Scientific Session, 1/1/2006
• A Novel and Independent Heart Rate Recovery Parameter Prognostic for Cardiovascular Death
  David M. Hadley, James V. Freeman, Frederick E. Dewey, Gregory Engel, Victor F. Froelicher, Heart Rhythm Society Annual Scientific Sessions, 1/1/2006
• Integrated Exercise Induced Temporal and Spectral Heart Rate Variability Is a Powerful Prognostic Marker for Cardiovascular Death
  David M. Hadley, James V. Freeman, Frederick E. Dewey, Gregory Engel, Victor F. Froelicher, Heart Rhythm Society Annual Scientific Sessions, 1/1/2006
• Heart Rate Variability Time and Frequency Domain Changes with Increasing Altitude
  James V. Freeman, Frederick E. Dewey, Victor F. Froelicher, American College of Physicians Northern California Regional Conference, 1/1/2005
• Join now to see all

Lectures

• Outcomes in ICD Populations 
  1/1/2014
• Digoxin and Risk of Death in Adults with Atrial Fibrillation: The ATRIA-CVRN Study 
  1/1/2013
• Minimally Invasive Surgical Ablation is Better than Catheter Ablation of Atrial Fibrillation 
  1/1/2013
• Optimizing the Quality of Perioperative Care: How Do We Bridge the Evidence Gaps? 
  1/1/2013
• Contemporary Effectiveness and Safety of Digoxin in Adults with Incident Systolic Heart Failure 
  1/1/2011
• Cost-effectiveness of percutaneous closure of the left atrial appendage compared with warfarin and dabigatran in nonvalvular atrial fibrillation 
  1/1/2011
• Physician Procedure Volume and Complications of Cardioverter-Defibrillator Implantation 
  1/1/2011
• Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in nonvalvular atrial fibrillation 
  1/1/2010
• The Relation between Hospital Procedure Volume and Complications of Cardioverter-Defibrillator Implantation from the National Cardiovascular Data Registry 
  1/1/2010
• Estrogen receptor alpha mediates the radioprotective effect of tamoxifen through prophylactic induction of apoptosis in newly transformed cells 
  1/1/2001
• Join now to see all

Other

• Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation: Results from RAAFT-2. Arrhythmias & Clinical EP Clinical Top... 
  Freeman JV
  1/1/2014